Importantly, we further demonstrated that enforced c-MYC (over)expression sensitizes MM cells to both DNMT3B depletion and NA treatment, while DNMT3B mRNA and protein levels were significantly increased in these MYC-overexpressing cells. The gene discussed is MYC; the disease is Miyoshi myopathy.